Statement of Retraction: Minimal stimulation or clomiphene citrate as first-line therapy in women with polycystic ovary syndrome: a randomized controlled trial
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Gynecological Endocrinology |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2023.2272096 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statement of Retraction: Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial
Published: (2024-12-01) -
Statement of Retraction: Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial
Published: (2024-12-01) -
Statement of retraction: Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial
Published: (2024-12-01) -
Letrozole versus coenzyme Q10 plus Clomiphene citrate for women with Polycystic Ovarian Syndrome: An efficacy and safety analysis
by: Juan Hou, et al.
Published: (2025-04-01) -
Effects of letrozole combined with clomiphene in the treatment of polycystic ovary syndrome: a meta-analysis
by: Baoying Du, et al.
Published: (2025-07-01)